Hiroko Kanda

1.2k total citations
55 papers, 823 citations indexed

About

Hiroko Kanda is a scholar working on Rheumatology, Immunology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Hiroko Kanda has authored 55 papers receiving a total of 823 indexed citations (citations by other indexed papers that have themselves been cited), including 26 papers in Rheumatology, 17 papers in Immunology and 10 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Hiroko Kanda's work include Systemic Lupus Erythematosus Research (13 papers), Rheumatoid Arthritis Research and Therapies (10 papers) and T-cell and B-cell Immunology (6 papers). Hiroko Kanda is often cited by papers focused on Systemic Lupus Erythematosus Research (13 papers), Rheumatoid Arthritis Research and Therapies (10 papers) and T-cell and B-cell Immunology (6 papers). Hiroko Kanda collaborates with scholars based in Japan and United States. Hiroko Kanda's co-authors include Kazuhiko Yamamoto, Toshihide Mimura, Kanae Kubo, Keishi Fujio, Ken Hamasaki, Kojiro Sato, Yasuo Nagafuchi, Shuji Sumitomo, Yumi Tsuchida and Yoshikata Misaki and has published in prestigious journals such as Scientific Reports, Biochemical and Biophysical Research Communications and Kidney International.

In The Last Decade

Hiroko Kanda

53 papers receiving 802 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Hiroko Kanda Japan 18 300 273 130 112 110 55 823
Szilvia Szamosi Hungary 20 286 1.0× 386 1.4× 235 1.8× 158 1.4× 88 0.8× 58 1.0k
Shizuyo Tsujimura Japan 16 286 1.0× 539 2.0× 101 0.8× 81 0.7× 92 0.8× 33 969
Bonnie Mitchell United States 14 223 0.7× 213 0.8× 155 1.2× 67 0.6× 81 0.7× 28 804
Masafumi Sugiyama Japan 16 336 1.1× 362 1.3× 324 2.5× 77 0.7× 66 0.6× 47 817
Allen R. Hendricks United States 8 446 1.5× 600 2.2× 129 1.0× 81 0.7× 72 0.7× 16 913
Tsai-Hung Wu Taiwan 14 323 1.1× 301 1.1× 196 1.5× 37 0.3× 80 0.7× 32 710
Xiaoping Qing United States 15 540 1.8× 390 1.4× 237 1.8× 64 0.6× 61 0.6× 23 1.1k
Yeong‐Jian Jan Wu Taiwan 16 279 0.9× 537 2.0× 173 1.3× 284 2.5× 117 1.1× 38 970
Philip Ruiz United States 17 260 0.9× 151 0.6× 103 0.8× 62 0.6× 96 0.9× 30 795
Giovanna A. Giannico United States 18 161 0.5× 241 0.9× 213 1.6× 96 0.9× 271 2.5× 64 936

Countries citing papers authored by Hiroko Kanda

Since Specialization
Citations

This map shows the geographic impact of Hiroko Kanda's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hiroko Kanda with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hiroko Kanda more than expected).

Fields of papers citing papers by Hiroko Kanda

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hiroko Kanda. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hiroko Kanda. The network helps show where Hiroko Kanda may publish in the future.

Co-authorship network of co-authors of Hiroko Kanda

This figure shows the co-authorship network connecting the top 25 collaborators of Hiroko Kanda. A scholar is included among the top collaborators of Hiroko Kanda based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hiroko Kanda. Hiroko Kanda is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Li, Lixin, Yukiko Ito, Hiroko Kanda, et al.. (2024). Prevalence of antiphospholipid autoantibodies associated with biologics treatment for psoriasis. Scientific Reports. 14(1).
3.
Inoue, Mariko, Yasuo Nagafuchi, Mineto Ota, et al.. (2023). Carriers of HLA-DRB1*04:05 have a better clinical response to abatacept in rheumatoid arthritis. Scientific Reports. 13(1). 15250–15250. 12 indexed citations
4.
Fukasawa, Takemichi, Takashi Yamashita, Atsushi Enomoto, et al.. (2023). The optimal use of tildrakizumab in the elderly via improvement of Treg function and its preventive effect of psoriatic arthritis. Frontiers in Immunology. 14. 1286251–1286251. 12 indexed citations
5.
Sakurai, Keiichi, Kazuyoshi Ishigaki, Hirofumi Shoda, et al.. (2018). HLA-DRB1 Shared Epitope Alleles and Disease Activity Are Correlated with Reduced T Cell Receptor Repertoire Diversity in CD4+ T Cells in Rheumatoid Arthritis. The Journal of Rheumatology. 45(7). 905–914. 24 indexed citations
6.
Nakachi, Shinichiro, Shuji Sumitomo, Yumi Tsuchida, et al.. (2017). Interleukin-10-producing LAG3+ regulatory T cells are associated with disease activity and abatacept treatment in rheumatoid arthritis. Arthritis Research & Therapy. 19(1). 97–97. 52 indexed citations
7.
Nagafuchi, Yasuo, Hirofumi Shoda, Shuji Sumitomo, et al.. (2016). Immunophenotyping of rheumatoid arthritis reveals a linkage between HLA-DRB1 genotype, CXCR4 expression on memory CD4+ T cells and disease activity. Scientific Reports. 6(1). 29338–29338. 45 indexed citations
8.
Shoda, Hirofumi, Kaoru Morita, Hiroko Kanda, Keishi Fujio, & Kazuhiko Yamamoto. (2014). An elderly woman with peripheral spondyloarthritis with aortitis. Modern Rheumatology. 24(2). 353–356. 3 indexed citations
9.
Kanda, Hiroko, Junji Koya, Hiroshi Uozaki, et al.. (2013). Membranous nephropathy with repeated flares in IgG4-related disease. Clinical Kidney Journal. 6(2). 204–207. 12 indexed citations
10.
Kawahata, Kimito, et al.. (2012). Long-term therapeutic effects and safety of tacrolimus added to methotrexate in patients with rheumatoid arthritis. Rheumatology International. 33(4). 871–877. 7 indexed citations
11.
Sakoda, Hideyuki, Shizuo Ito, Hiroko Kanda, et al.. (2010). Association between type 1 diabetes mellitus and remitting seronegative symmetrical synovitis with pitting edema: A case report. Diabetes Research and Clinical Practice. 91(2). e43–e44. 9 indexed citations
12.
Son, Daisuke, Hiroko Kanda, Akihiro Yamaguchi, et al.. (2009). Myeloperoxidase antineutrophil cytoplasmic antibody-associated vasculitis with diffuse tubulointerstitial nephritis. Journal of Nephrology. 22(3). 417–420. 10 indexed citations
13.
Takizawa, Yasunobu, Hiroko Kanda, Kojiro Sato, et al.. (2006). Polymyositis associated with focal mesangial proliferative glomerulonephritis with depositions of immune complexes. Clinical Rheumatology. 26(5). 792–796. 18 indexed citations
14.
Sato, Kojiro, et al.. (2005). Downregulation of IL-12 and a novel negative feedback system mediated by CD25+CD4+ T cells. Biochemical and Biophysical Research Communications. 330(1). 226–232. 14 indexed citations
15.
Kanda, Hiroko, Yoshikuni Kita, Tomonori Okamura, et al.. (2004). What factors are associated with high plasma B-type natriuretic peptide levels in a general Japanese population?. Journal of Human Hypertension. 19(2). 165–172. 38 indexed citations
16.
Hamasaki, Ken, Toshihide Mimura, Hiroko Kanda, et al.. (2003). Systemic lupus erythematosus and thrombotic thrombocytopenic purpura: a case report and literature review. Clinical Rheumatology. 22(4-5). 355–358. 52 indexed citations
17.
Kanda, Hiroko, Kanae Kubo, Ken Hamasaki, et al.. (2001). Influence of various hemodialysis membranes on the plasma (1→3)-β-D-glucan level. Kidney International. 60(1). 319–323. 73 indexed citations
18.
Kanda, Hiroko. (2001). Inhibitors of arachidonic acid metabolism have variable effects on calcium signaling pathways. American Journal of Hypertension. 14(3). 248–253. 5 indexed citations
19.
20.
Hara, Yasushi, et al.. (1993). Prolonged survival of rat cardiac allografts induced by intrathymic injection of donor bone marrow cells.. PubMed. 25(6). 3283–5. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Szilvia Szamosi Breakdown of academic impact, for papers by Shizuyo Tsujimura Breakdown of academic impact, for papers by Bonnie Mitchell Breakdown of academic impact, for papers by Masafumi Sugiyama Breakdown of academic impact, for papers by Allen R. Hendricks Breakdown of academic impact, for papers by Tsai-Hung Wu Breakdown of academic impact, for papers by Xiaoping Qing Breakdown of academic impact, for papers by Yeong‐Jian Jan Wu Breakdown of academic impact, for papers by Philip Ruiz Breakdown of academic impact, for papers by Giovanna A. Giannico
Rankless by CCL
2026